Alan P. Venook

University of California, San Francisco — United States

Medicine · Health Sciences

95h-index42.0kcitations775works4.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Colorectal Cancer Treatments and Studies(302), Hepatocellular Carcinoma Treatment and Prognosis(147), Cancer Genomics and Diagnostics(113), Gastric Cancer Management and Outcomes(94), Genetic factors in colorectal cancer(85)

Publications774 total

Shifts in the human gut microbiome during cancer chemotherapy are diet-dependent
2026Open Access
Shifts in the human gut microbiome during cancer chemotherapy are diet-dependent
2025Open Access
Gene signatures derived from transcriptomic-causal networks stratify colorectal cancer patients for effective targeted therapy
UNC Libraries·2025Open Access
Radiomic signatures to estimate survival in patients with advanced hepatocellular carcinoma treated with sorafenib: Cancer and Leukemia Group B 80802 (Alliance)
ESMO Open·2025Open Access
Supplementary Table S2 from Plasma 25-Hydroxyvitamin D Levels and Survival in Stage III Colon Cancer: Findings from CALGB/SWOG 80702 (Alliance)
2025Open Access
Supplementary Figure S2 from Plasma 25-Hydroxyvitamin D Levels and Survival in Stage III Colon Cancer: Findings from CALGB/SWOG 80702 (Alliance)
2025Open Access
Supplementary Figure S1 from Plasma 25-Hydroxyvitamin D Levels and Survival in Stage III Colon Cancer: Findings from CALGB/SWOG 80702 (Alliance)
2025Open Access
Supplementary Table S1 from Plasma 25-Hydroxyvitamin D Levels and Survival in Stage III Colon Cancer: Findings from CALGB/SWOG 80702 (Alliance)
2025Open Access
Supplementary Methods S1 from Plasma 25-Hydroxyvitamin D Levels and Survival in Stage III Colon Cancer: Findings from CALGB/SWOG 80702 (Alliance)
2025Open Access
Supplementary Table S3 from Plasma 25-Hydroxyvitamin D Levels and Survival in Stage III Colon Cancer: Findings from CALGB/SWOG 80702 (Alliance)
2025Open Access
Supplementary Table S4 from Plasma 25-Hydroxyvitamin D Levels and Survival in Stage III Colon Cancer: Findings from CALGB/SWOG 80702 (Alliance)
2025Open Access
Supplementary Table S5 from Plasma 25-Hydroxyvitamin D Levels and Survival in Stage III Colon Cancer: Findings from CALGB/SWOG 80702 (Alliance)
2025Open Access
Supplementary Figure S3 from Plasma 25-Hydroxyvitamin D Levels and Survival in Stage III Colon Cancer: Findings from CALGB/SWOG 80702 (Alliance)
2025Open Access
Genomic Analysis of Germline Variation Associated with Survival of Patients with Colorectal Cancer Treated with Chemotherapy Plus Biologics in CALGB/SWOG 80405 (Alliance)
UNC Libraries·2025Open Access
705 Immunosuppressive CD14 <sup>+</sup> monocytes are enriched in patients with hepatocellular carcinoma and worse liver function (child-pugh B) and are associated with unfavorable immunotherapy outcomes
Regular and Young Investigator Award Abstracts·2025Open Access
Chronological survival improvement over time with oxaliplatin-based chemotherapy plus targeted agents in metastatic colorectal cancer: An ARCAD database study
European Journal of Cancer·2025Open Access
GABAergic signaling contributes to tumor cell invasion and poor overall survival in colorectal cancer
UNC Libraries·2025Open Access
Impact of Human Epidermal Growth Factor Receptor 2 in Patients With Metastatic Colorectal Cancer Treated With Chemotherapy Plus Bevacizumab or Anti-EGFRs: Exploratory Analysis of Eight Randomized Trials
Journal of Clinical Oncology·2025· 7 citedOpen Access
Randomized Phase II Trial of Pazopanib Versus Placebo in Patients With Advanced Extrapancreatic Neuroendocrine Tumors (Alliance A021202)
Journal of Clinical Oncology·2025· 1 citedOpen Access
Biliary Tract Cancers, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology
Journal of the National Comprehensive Cancer Network·2025· 7 cited
page 1 of 39Next →

Frequent Co-authors

Al B. Benson(20), Leonard B. Saltz(16), Jeffrey A. Meyerhardt(14), Wells A. Messersmith(11), John M. Skibber(11), Harry S. Cooper(10), Jean L. Grem(10), Steven R. Hunt(10), Mary F. Mulcahy(10), Steven Nurkin(10), David Shibata(10), Constantinos T. Sofocleous(10), Christopher G. Willett(10), Dustin A. Deming(9), Natalie Kirilcuk(9), Eden Stotsky‐Himelfarb(9), Howard S. Höchster(9), Sarah E. Hoffe(8), Smitha Krishnamurthi(8), Elena M. Stoffel(8)